Pharmascience, a generic pharmaceutical company, announced today that it has acquired Aegera Therapeutics Inc., a Montreal based clinical-stage biotechnology company focused on developing targeted therapeutics to address...
To Read This Article, Please Login or Subscribe
For $5 plus HST a month (recurring), you will have access to all our premium contents (database access is not included). For database subscription, please click here.
